Feedback / Questions
NT102 - Neuroene Therap
https://www.prnewswire.com/news-releases/neuroene-therapeutics-announces-orphan-drug-designation-granted-by-fda-for-dravet-syndrome-treatment--nt102-301411587.html
 
Oct 29, 2021
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious